Tetravil

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTetravil
Drug Alias NameF-16-IL-4 fusion protein (Philogen)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionInterleukin-4 receptor subunit alpha agonistsTenascin modulators
TargetsInterleukin-4 receptor subunit alphaTenascin
Therapy Area/IndicationsPsoriasisEndometriosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhilogen Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhilogen Spa
Active IndicationsN/A
Inactive IndicationsPsoriasisEndometriosisArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A